For the Inventor, By the Inventor

Enter assignee name

Ingelheim am Rhein, Germany

Boehringer Ingelheim Gmbh

USPTO Granted Patents = 306

EPO Patents = 4

Trademarks = 2

Forward Citations = 4,137

Loading Chart...

Loading Chart...

315 inventors (with patents filed for the assignee):

Herbert Koppe (50 out of 65 patents)

Helmut Stahle (39 out of 50 patents)

Werner Kummer (39 out of 51 patents)

4. Kurt Schromm (34 out of 68 patents)

5. Anton Mentrup (34 out of 46 patents)

6. Ernst-Otto Renth (31 out of 51 patents)

7. Adolf Langbein (26 out of 28 patents)

8. Wolfgang Hoefke (26 out of 38 patents)

9. Herbert Merz (24 out of 36 patents)

10. Klaus Stockhaus (24 out of 30 patents)

11. Gerhard Walther (22 out of 52 patents)

12. Werner Traunecker (21 out of 29 patents)

13. Walter Haarmann (18 out of 31 patents)

14. Gunther Engelhardt (17 out of 28 patents)

15. Walter Kobinger (16 out of 33 patents)

Core Competencies:

Pharmaceutical Blister

Dry Powder Inhaler

Viral Polymerase Inhibitors

Peptidomimetic Inhibitors

Dihydropyridines

Endosomolytic Agents

Xanthine Derivatives

Quinuclidines

Biodegradable Systems

Cyclic Amine Derivatives

Antidepressant Agents

Tumor Treatment Methods

306 patents: Sort by Forward Citations

1. 7758936 - Pharmaceutical blister (2010-07-20),

2. 7694676 - Dry powder inhaler (2010-04-13),

3. 7226747 - Method of identifying substances which modulate interleukin 4(IL-4) signaling (2007-06-05),

4. 6841566 - Viral polymerase inhibitors (2005-01-11),

5. 6685691 - Container for a medicinal liquid (2004-02-03),

6. 6465483 - Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations (2002-10-15),

7. 6402055 - Device for producing high pressure in a fluid in miniature (2002-06-11),

8. 6291640 - Peptidomimetic inhibitors of the human cytomegalovirus protease (2001-09-18),

9. 6180645 - Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations (2001-01-30),

10. 6136819 - Annelated dihydropyridines and the use thereof for preparing (2000-10-24),

11. 6071939 - Medicaments for the treatment of hypertension (2000-06-06),

12. 5981273 - Composition comprising an endosomolytic agent for introducing nucleic (1999-11-09),

13. 5964416 - Device for producing high pressure in a fluid in miniature (1999-10-12),

14. 5922878 - Amino acid derivatives, processes for preparing them and pharmaceutical (1999-07-13),

15. 5843441 - Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in (1998-12-01),

Boehringer Ingelheim is a global pharmaceutical company that specializes in researching, developing, and manufacturing innovative medicines. With a focus on improving human and animal health, Boehringer Ingelheim's diverse portfolio includes prescription drugs, over-the-counter medications, and veterinary products. Their mission is to make a significant impact on the lives of patients and communities by delivering breakthrough therapies and integrated healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

306 Patents

#2 in Ingelheim am Rhein

#211 in Germany

#2,834 in the World

Ingelheim am Rhein, Germany

Boehringer Ingelheim Gmbh

Forward Citations = 4,137

315 inventors:

Herbert Koppe (50 out of 65 patents)

Helmut Stahle (39 out of 50 patents)

Werner Kummer (39 out of 51 patents)

4. Kurt Schromm (34 out of 68 patents)

5. Anton Mentrup (34 out of 46 patents)

Please report any incorrect information to support@idiyas.com

Loading…